3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
5
Neoplasms
5
Multiple Myeloma
4
Neoplasms, Plasma Cell
3
Colorectal Neoplasms
3
Hematologic Neoplasms
2
Frailty
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Upper Excretory Tract Tumors
1
Transfusion-Related Acute Lung Injury
1
Thrombosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Sleep Initiation and Maintenance Disorders
1
Sleep Disorders, Circadian Rhythm
1
Sezary Syndrome
1
Sarcopenia
1
Sarcoglycanopathies
1
Psoriasis
1
Peripheral Arterial Disease
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Mycoses
1
Melanoma
1
Malnutrition
1
Interventions
Gene Expression Profiling
33
Flow Cytometry
30
Microarray Analysis
22
Polymerase Chain Reaction
21
Reverse Transcriptase Polymerase Chain Reaction
13
Amplified Fragment Length Polymorphism Analysis
11
Cytogenetic Analysis
10
Surveys and Questionnaires
9
DNA Methylation
9
Blotting, Western
9
Psychiatric Rehabilitation
8
Immunologic Techniques
8
Base Sequence
8
In Situ Hybridization, Fluorescence
6
Blood Specimen Collection
6
Interviews as Topic
5
Therapeutics
3
Immunoenzyme Techniques
3
Imatinib Mesylate
3
Gene Rearrangement
3
Watchful Waiting
2
Pharmacogenomic Testing
2
Mental Status and Dementia Tests
2
Mass Spectrometry
2
Genetic Testing
2
Data Collection
2
Dasatinib
2
Counseling
2
Cell Culture Techniques
2
Blotting, Southern
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Leukemia
×
Standard of Care
×
Clear all
NCT01254318
2016-11-02
TRAFIC
Merck Sharp & Dohme LLC
Completed
130 enrolled
5 charts